AG˹ٷ

STOCK TITAN

[Form 4] Vital Farms, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Vital Farms officer Joanne Bal reported the sale of 9,999 shares of the company's common stock on 08/15/2025 at a weighted average price of $47.70 per share, with transaction prices ranging from $47.60 to $47.81. After the sale, the reporting person beneficially owned 48,128 shares, a total that includes 229 shares acquired under the company's Employee Stock Purchase Plan on 05/15/2025. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing identifies the reporting person as an officer with the title GC, SEC. AND HEAD OF IMPACT.

La dirigente di Vital Farms, Joanne Bal, ha comunicato la vendita di 9.999 azioni ordinarie della società in data 15/08/2025 a un prezzo medio ponderato di 47,70 USD per azione, con transazioni comprese tra 47,60 e 47,81 USD. Dopo la vendita, la persona che effettua la segnalazione deteneva beneficiariamente 48.128 azioni, incluso un lotto di 229 azioni acquistate tramite il Piano di Acquisto Azionario per i Dipendenti dell'azienda il 15/05/2025. Il Modulo 4 è stato firmato da un mandatario legale in data 19/08/2025. La dichiarazione identifica la reporting person come dirigente con il titolo GC, responsabile SEC e Head of Impact.

La directiva de Vital Farms, Joanne Bal, informó la venta de 9.999 acciones ordinarias de la compañía el 15/08/2025 a un precio medio ponderado de 47,70 USD por acción, con precios de transacción que oscilaron entre 47,60 y 47,81 USD. Tras la venta, la persona que presenta el informe poseía beneficiariamente 48.128 acciones, cifra que incluye 229 acciones adquiridas mediante el Plan de Compra de Acciones para Empleados de la compañía el 15/05/2025. El Formulario 4 fue firmado por un apoderado el 19/08/2025. La presentación identifica a la informante como una directiva con el título GC, responsable ante la SEC y Head of Impact.

Vital Farms� 임원 Joanne Bal은 2025� 8� 15� 회사 보통� 9,999주를 주당 가중평� 가� 47.70달러� 매각했으�, 거래 가격은 47.60달러에서 47.81달러 사이였다고 보고했습니다. 매도 � 보고인은 48,128주를 실질적으� 보유하고 있었으며, � 중에� 2025� 5� 15� 회사� 직원 주식 매수 계획� 통해 취득� 229주가 포함됩니�. Form 4� 2025� 8� 19� 대리인� 서명했습니다. 신고서에� 해당 보고인을 GC, SEC 담당 � Head of Impact 직함� 가� 임원으로 명시하고 있습니다.

La dirigeante de Vital Farms, Joanne Bal, a déclaré la vente de 9 999 actions ordinaires de la société le 15/08/2025 au prix moyen pondéré de 47,70 USD par action, avec des prix de transaction allant de 47,60 à 47,81 USD. Après la vente, la personne déclaratrice détenait bénéficiairement 48 128 actions, dont 229 actions acquises dans le cadre du Plan d'Achat d'Actions pour les Employés de la société le 15/05/2025. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Le dépôt identifie la personne déclaratrice comme une dirigeante portant le titre GC, en charge des relations avec la SEC et Head of Impact.

Vital Farms-Vorständin Joanne Bal meldete den Verkauf von 9.999 Stammaktien des Unternehmens am 15.08.2025 zu einem gewichteten Durchschnittspreis von 47,70 USD je Aktie; die Transaktionspreise lagen zwischen 47,60 und 47,81 USD. Nach dem Verkauf besaß die meldende Person wirtschaftlich 48.128 Aktien, einschließlich 229 Aktien, die am 15.05.2025 über den Mitarbeiteraktienkaufplan des Unternehmens erworben wurden. Das Formular 4 wurde am 19.08.2025 durch einen Bevollmächtigten unterschrieben. Die Meldung bezeichnet die meldepflichtige Person als Führungskraft mit dem Titel GC, zuständig für die SEC, und Head of Impact.

Positive
  • Complete transaction disclosure including exact share count, weighted average price, and price range ( $47.60�$47.81 ).
  • Post-transaction holdings clarified with explicit inclusion of 229 ESPP shares acquired on 05/15/2025.
  • Commitment to provide per-trade pricing details upon request improves transparency.
Negative
  • Officer disposed of 9,999 shares, which may be viewed unfavorably by some investors even though no further context is provided.

Insights

TL;DR: An officer sale of 9,999 shares was disclosed; transaction details and remaining holdings are clearly reported.

The Form 4 documents a non-derivative disposition of 9,999 shares by Joanne Bal on 08/15/2025 at a weighted average price of $47.70, with prices in a disclosed range of $47.60 to $47.81. The report also states the reporting person retains 48,128 shares following the sale, which explicitly includes 229 shares acquired via the Employee Stock Purchase Plan on 05/15/2025. The filing provides a footnote committing to provide per-trade pricing details upon request, which enhances transparency. No other executions, derivative transactions, or changes to compensation arrangements are disclosed in this filing.

TL;DR: Disclosure is complete for the reported sale and includes provenance of residual shares, meeting Form 4 requirements.

The Form 4 identifies the reporting person's relationship to the issuer and provides the required details for the sale: transaction date, quantity sold, weighted average price, and post-transaction beneficial ownership. The inclusion of the ESPP-acquired 229 shares and the footnote about price breakdowns indicates attention to disclosure detail. The form is executed by an attorney-in-fact and dated 08/19/2025, satisfying signature formalities.

La dirigente di Vital Farms, Joanne Bal, ha comunicato la vendita di 9.999 azioni ordinarie della società in data 15/08/2025 a un prezzo medio ponderato di 47,70 USD per azione, con transazioni comprese tra 47,60 e 47,81 USD. Dopo la vendita, la persona che effettua la segnalazione deteneva beneficiariamente 48.128 azioni, incluso un lotto di 229 azioni acquistate tramite il Piano di Acquisto Azionario per i Dipendenti dell'azienda il 15/05/2025. Il Modulo 4 è stato firmato da un mandatario legale in data 19/08/2025. La dichiarazione identifica la reporting person come dirigente con il titolo GC, responsabile SEC e Head of Impact.

La directiva de Vital Farms, Joanne Bal, informó la venta de 9.999 acciones ordinarias de la compañía el 15/08/2025 a un precio medio ponderado de 47,70 USD por acción, con precios de transacción que oscilaron entre 47,60 y 47,81 USD. Tras la venta, la persona que presenta el informe poseía beneficiariamente 48.128 acciones, cifra que incluye 229 acciones adquiridas mediante el Plan de Compra de Acciones para Empleados de la compañía el 15/05/2025. El Formulario 4 fue firmado por un apoderado el 19/08/2025. La presentación identifica a la informante como una directiva con el título GC, responsable ante la SEC y Head of Impact.

Vital Farms� 임원 Joanne Bal은 2025� 8� 15� 회사 보통� 9,999주를 주당 가중평� 가� 47.70달러� 매각했으�, 거래 가격은 47.60달러에서 47.81달러 사이였다고 보고했습니다. 매도 � 보고인은 48,128주를 실질적으� 보유하고 있었으며, � 중에� 2025� 5� 15� 회사� 직원 주식 매수 계획� 통해 취득� 229주가 포함됩니�. Form 4� 2025� 8� 19� 대리인� 서명했습니다. 신고서에� 해당 보고인을 GC, SEC 담당 � Head of Impact 직함� 가� 임원으로 명시하고 있습니다.

La dirigeante de Vital Farms, Joanne Bal, a déclaré la vente de 9 999 actions ordinaires de la société le 15/08/2025 au prix moyen pondéré de 47,70 USD par action, avec des prix de transaction allant de 47,60 à 47,81 USD. Après la vente, la personne déclaratrice détenait bénéficiairement 48 128 actions, dont 229 actions acquises dans le cadre du Plan d'Achat d'Actions pour les Employés de la société le 15/05/2025. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Le dépôt identifie la personne déclaratrice comme une dirigeante portant le titre GC, en charge des relations avec la SEC et Head of Impact.

Vital Farms-Vorständin Joanne Bal meldete den Verkauf von 9.999 Stammaktien des Unternehmens am 15.08.2025 zu einem gewichteten Durchschnittspreis von 47,70 USD je Aktie; die Transaktionspreise lagen zwischen 47,60 und 47,81 USD. Nach dem Verkauf besaß die meldende Person wirtschaftlich 48.128 Aktien, einschließlich 229 Aktien, die am 15.05.2025 über den Mitarbeiteraktienkaufplan des Unternehmens erworben wurden. Das Formular 4 wurde am 19.08.2025 durch einen Bevollmächtigten unterschrieben. Die Meldung bezeichnet die meldepflichtige Person als Führungskraft mit dem Titel GC, zuständig für die SEC, und Head of Impact.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bal Joanne

(Last) (First) (Middle)
C/O VITAL FARMS, INC.
3601 SOUTH CONGRESS AVENUE, SUITE C100

(Street)
AUSTIN TX 78704

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
GC, SEC. AND HEAD OF IMPACT
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 S 9,999 D $47.7(1) 48,128(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.60 to $47.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. Includes 229 shares that were acquired on May 15, 2025 under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Francis Cullo, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Vital Farms (VITL) officer Joanne Bal report on Form 4?

The filing reports a sale of 9,999 shares on 08/15/2025.

At what price were the shares sold in the VITL Form 4 filing?

The shares were sold at a weighted average price of $47.70 per share with individual trade prices ranging from $47.60 to $47.81.

How many Vital Farms shares does the reporting person own after the reported sale?

The reporting person beneficially owned 48,128 shares following the transaction.

Does the Form 4 identify the reporting person's role at Vital Farms?

Yes; the filing lists the reporting person as an Officer with the title GC, SEC. AND HEAD OF IMPACT.

Are there any shares acquired under an employee plan included in the reported holdings?

Yes; the post-transaction total includes 229 shares acquired under the Employee Stock Purchase Plan on 05/15/2025.

When was the Form 4 signed and filed?

The signature on the form is dated 08/19/2025 and executed by an attorney-in-fact.
Vital Farms, Inc.

NASDAQ:VITL

VITL Rankings

VITL Latest News

VITL Latest SEC Filings

VITL Stock Data

2.21B
34.53M
22.56%
94.05%
17.25%
Farm Products
Food and Kindred Products
United States
AUSTIN